Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Insulin Resistance Index in Plasma Neuronal Exosomes As Predictive Biomarkers of Alzheimer's Disease

NCT06825663 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT06825663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06825663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Insulin Resistance Index in Plasma Neuronal Exosomes As Predictive Biomarkers of Alzheimer's Disease
Lead sponsor
Central Hospital, Nancy, France
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 15, 2025
Completion date
September 1, 2028
Enrollment
122 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain insuline resistance, mild cognitive impairment, prognosis biomarker of ad